Exhibit 107
Calculation of Filing Fee Table
Form F-1
(Form Type)
Galmed Pharmaceuticals Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Share(2)(3) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||
| Equity | Ordinary shares, par value NIS 1.80 per share | 457(c) | 1,000,000 | (4) | $ | 3.54 | $ | 3,540,000 | 0.0001531 | $ | 541.97 | |||||||||||||
| Total Offering Amount | 1,000,000 | $ | 3,540,000 | $ | 541.97 | |||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $ | 541.97 | ||||||||||||||||||||||
| (1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Registrant is also registering hereunder an indeterminate number of additional ordinary shares that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act and based upon the average of the high and low sale prices of the Registrant’s ordinary shares on the Nasdaq Capital Market on October 17, 2024, which was $3.54. |
| (3) | The Registrant will not receive any proceeds from the sale of its ordinary shares by the selling shareholder. |
| (4) | All of the ordinary shares are to be offered for resale by the selling shareholder named in the prospectus contained in this Registration Statement on Form F-1 |
